These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2643621)

  • 21. In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteria.
    Wexler HM; Finegold SM
    Antimicrob Agents Chemother; 1988 Apr; 32(4):601-4. PubMed ID: 3163908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
    Aldridge KE
    Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Activity of cefotetan against anaerobic bacteria].
    Sedallian A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Criteria for in vitro susceptibility testing of cefotetan. Correlations with clinical and bacteriologic responses.
    Barry AL
    Am J Surg; 1988 May; 155(5A):24-9. PubMed ID: 3287965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
    Sedallian A; Roudon T
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of spiral gradient endpoint and agar dilution methods for susceptibility testing of anaerobic bacteria: a multilaboratory collaborative evaluation.
    Wexler HM; Molitoris E; Murray PR; Washington J; Zabransky RJ; Edelstein PH; Finegold SM
    J Clin Microbiol; 1996 Jan; 34(1):170-4. PubMed ID: 8748295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of three of the newer quinolones against anaerobic bacteria.
    Wexler HM; Molitoris E; Finegold SM
    Antimicrob Agents Chemother; 1992 Jan; 36(1):239-43. PubMed ID: 1317149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility testing of 7 antibiotics against anaerobic bacteria: comparison of 2 different media and carbon dioxide concentrations.
    Jansen JE; Bremmelgaard A
    Acta Pathol Microbiol Immunol Scand B; 1987 Feb; 95(1):65-73. PubMed ID: 3105247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of predictability of cefotetan in vitro susceptibility tests against cefotetan-resistant anaerobic bacteria in determining clinical and bacteriologic efficacies.
    Sheikh W; Bobey DG
    Diagn Microbiol Infect Dis; 1992; 15(7):595-600. PubMed ID: 1424516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of susceptibility of anaerobic bacteria to beta-lactam antibiotics by a tablet diffusion test.
    Jansen JE; Bremmelgaard A
    APMIS; 1988 May; 96(5):464-70. PubMed ID: 3259887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of minimum inhibitory concentrations of cefoperazone for control and reference anaerobic organisms.
    Zabransky RJ; Randall E; Sutter VL; Birk RJ; Westenfelder G; Emmerman J; Ghoneim AT
    J Clin Microbiol; 1983 Apr; 17(4):711-4. PubMed ID: 6222065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.
    Zabinski RA; Vance-Bryan K; Krinke AJ; Walker KJ; Moody JA; Rotschafer JC
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2454-8. PubMed ID: 8285633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of anaerobic susceptibility results obtained by two methods of inoculum preparation.
    Bourgault AM; Lamothe F
    J Clin Microbiol; 1984 Dec; 20(6):1060-4. PubMed ID: 6520217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro activity of cefoxitin vs. cefotetan against clinical isolates of Bacteroides and Prevotella species.
    Grossmeyer TJ; Farmer SG
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S353-6. PubMed ID: 8324146
    [No Abstract]   [Full Text] [Related]  

  • 35. Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis.
    Goldstein EJ; Citron DM; Merriam CV; Abramson MA
    Surg Infect (Larchmt); 2009 Apr; 10(2):111-8. PubMed ID: 19226203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of susceptibilities of anaerobic bacteria determined by agar dilution and by a microbroth method.
    Baron EJ; Bruckner DA
    Rev Infect Dis; 1984; 6 Suppl 1():S249-53. PubMed ID: 6718938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative activity of several beta-lactam antibiotics against anaerobes determined by two methods.
    Zabransky RJ; Birk RJ
    Clin Ther; 1987; 10(1):107-25. PubMed ID: 3450391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in vitro beta-lactam activity against aerobic and anaerobic surgical isolates.
    Edmiston CE; Krepel CJ; Clausz JC; Condon RE
    Diagn Microbiol Infect Dis; 1988 Feb; 9(2):105-13. PubMed ID: 3164263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the in vitro inhibitory and bactericidal activity of ceftizoxime, cefoxitin, cefotetan, and penicillin G against Bacteroides fragilis group isolates. Comparison of time-kill kinetic studies with MIC values.
    Aldridge KE; Weeks LS; Stratton CW; Sanders CV
    Diagn Microbiol Infect Dis; 1990; 13(4):311-6. PubMed ID: 2076592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.